𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Characterization of crosslinked high amylose starch matrix implants: 1. In vitro release of ciprofloxacin

✍ Scribed by Cyril Désévaux; Pascal Dubreuil; Vincent Lenaerts

Book ID
114161774
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
661 KB
Volume
82
Category
Article
ISSN
0168-3659

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevention and treatment of experimental
Prevention and treatment of experimental osteomyelitis in dogs with ciprofloxacin-loaded crosslinked high amylose starch implants
✍ Louis M. Huneault; Bertrand Lussier; Pascal Dubreuil; Luc Chouinard; Cyril Désév 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 759 KB

## Abstract Crosslinked high amylose starch (CLHAS) matrix was used as a biodegradable drug delivery implant for the prevention and treatment of osteomyelitis. Thirty‐two dogs underwent the femoral insertion of a screw inoculated with __Staphylococcus aureus__ and were then randomly assigned to fou

Novel biopolymers as implant matrix for
Novel biopolymers as implant matrix for the delivery of ciprofloxacin: Biocompatibility, degradation, and in vitro antibiotic release
✍ Suniket V. Fulzele; Prashant M. Satturwar; Avinash K. Dorle 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB 👁 1 views

The purpose of this study was to investigate the in vitro-in vivo degradation and tissue compatibility of three novel biopolymers viz. polymerized rosin (PR), glycerol ester of polymerized rosin (GPR) and pentaerythritol ester of polymerized rosin (PPR) and study their potential as implant matrix fo